176 related articles for article (PubMed ID: 24937038)
1. Artificial pancreas: fuzzy logic and control of glycemia.
Nimri R; Phillip M
Curr Opin Endocrinol Diabetes Obes; 2014 Aug; 21(4):251-6. PubMed ID: 24937038
[TBL] [Abstract][Full Text] [Related]
2. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.
Thabit H; Lubina-Solomon A; Stadler M; Leelarathna L; Walkinshaw E; Pernet A; Allen JM; Iqbal A; Choudhary P; Kumareswaran K; Nodale M; Nisbet C; Wilinska ME; Barnard KD; Dunger DB; Heller SR; Amiel SA; Evans ML; Hovorka R
Lancet Diabetes Endocrinol; 2014 Sep; 2(9):701-9. PubMed ID: 24943065
[TBL] [Abstract][Full Text] [Related]
3. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.
Nimri R; Atlas E; Ajzensztejn M; Miller S; Oron T; Phillip M
Diabetes Technol Ther; 2012 Aug; 14(8):728-35. PubMed ID: 22853723
[TBL] [Abstract][Full Text] [Related]
5. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
6. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
[TBL] [Abstract][Full Text] [Related]
7. Bringing closed-loop home: recent advances in closed-loop insulin delivery.
Thabit H; Hovorka R
Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):95-101. PubMed ID: 24569550
[TBL] [Abstract][Full Text] [Related]
8. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
9. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
[TBL] [Abstract][Full Text] [Related]
10. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
[TBL] [Abstract][Full Text] [Related]
11. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
[TBL] [Abstract][Full Text] [Related]
12. [What is the current state of the artificial pancreas in diabetes care?].
Dimou M; Laimer M; Stettler C; Bally L
Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
[TBL] [Abstract][Full Text] [Related]
13. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.
Thabit H; Elleri D; Leelarathna L; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Barnard KD; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 May; 17(5):452-8. PubMed ID: 25492378
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal glucose control with an artificial pancreas at a diabetes camp.
Phillip M; Battelino T; Atlas E; Kordonouri O; Bratina N; Miller S; Biester T; Stefanija MA; Muller I; Nimri R; Danne T
N Engl J Med; 2013 Feb; 368(9):824-33. PubMed ID: 23445093
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
[No Abstract] [Full Text] [Related]
16. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.
Tauschmann M; Thabit H; Leelarathna L; Elleri D; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2015 Oct; 9(6):1346-7. PubMed ID: 26451010
[No Abstract] [Full Text] [Related]
18. Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story.
Bally L; Thabit H; Hovorka R
Int J Pharm; 2018 Jun; 544(2):309-318. PubMed ID: 29258910
[TBL] [Abstract][Full Text] [Related]
19. Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes.
Tauschmann M; Hovorka R
Expert Opin Drug Deliv; 2017 Dec; 14(12):1367-1377. PubMed ID: 28819992
[TBL] [Abstract][Full Text] [Related]
20. [Closed-Loop at night for the treatment of type 1 diabetes].
Danne T; Kordonouri O
Dtsch Med Wochenschr; 2014 Oct; 139(42):2156. PubMed ID: 25289927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]